ArticleScientific reports2017

Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells.

Pritha Mukherjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.